2005 Annual Meeting | Acute Stroke Management

Date Saturday 04/09/05

Time 06:00 PM - 08:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Kick-Off Program

Director(s) Lawrence R. Wechsler, MD, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Upon completion:
Participants should become familiar with the diagnostic approach to the acute stroke patient; understand the data supporting various acute stroke therapies including medical management, thrombolytics, neuroprotectants, and interventional treatments; and learn how new approaches, such as imaging, can improve acute stroke care by improving patient selection.

The American Board of Psychiatry and Neurology has reviewed Acute Stroke Management and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident, Nurse

Event Timeline
06:00 PM - 06:20 PM		Medical Management of Acute Ischemic Stroke Lawrence R. Wechsler, MD, FAAN
06:00 PM - 08:00 PM		Refreshments
06:20 PM - 06:40 PM		Update on Intravenous Thrombolysis Joseph P. Broderick, MD, FAAN
06:40 PM - 07:00 PM		Interventional Therapy for Acute Stroke Tudor G. Jovin, MD
07:00 PM - 07:20 PM		Selection of Patients for Acute Stroke Treatment Walter J. Koroshetz, MD, FAAN
07:20 PM - 08:00 PM		Acute Stroke Case Presentations

Faculty Disclosures
Joseph P. Broderick, MD, FAAN	Dr. Broderick has received publishing royalties from a publication relating to health care.
Walter J. Koroshetz, MD, FAAN	Dr. Koroshetz has nothing to disclose.
Lawrence R. Wechsler, MD, FAAN	Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices.
Tudor G. Jovin, MD	Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.

��ɫ��

��ɫ��